The U.S. Food and Drug Administration (FDA) today approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms...

As part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration today broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to...

Gilead Sciences, Inc. announced Monday that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Veklury® (remdesivir), an investigational antiviral for the...

By NewsDesk  @infectiousdiseasenews Singapore’s Health Sciences Authority (HSA) announced today granting conditional approval for Gilead Sciences Singapore Pte Ltd’s (Gilead) Veklury® (remdesivir). This...